Pacific Biosciences Of California (PACB) Current Assets (2010 - 2026)
Pacific Biosciences Of California (PACB) posted quarterly Current Assets of $369.5 million for Q1 2026, down 16.95% year-over-year from $444.9 million in Q1 2025, and down 1.48% quarter-over-quarter from $375.1 million in Q4 2025.
Pacific Biosciences Of California (PACB) Current Assets (2010 - 2026) Analysis & Trends
Pacific Biosciences Of California's Current Assets history runs 17 years deep, the most recent figure standing at $369.5 million for Q1 2026.
- In Q1 2026, Current Assets fell 16.95% year-over-year to $369.5 million; the TTM figure through Mar 2026 stood at $369.5 million (down 16.95% YoY), while the FY2025 annual figure was $375.1 million, down 24.34% from the prior year.
- Current Assets for Q1 2026 stood at $369.5 million, down from $375.1 million in the prior quarter.
- The five-year high for Current Assets was $1.0 billion in Q1 2022, with the low at $369.5 million in Q1 2026.
- The 5-year median for Current Assets is $677.0 million (2024), against an average of $687.6 million.
- The sharpest annual moves came in 2023 and 2025: Current Assets fell 3.46% in 2023, then sank 34.28% in 2025.
- Pacific Biosciences Of California's Current Assets stood at $852.1 million in 2022, then declined by 12.91% to $742.0 million in 2023, then slumped by 33.2% to $495.7 million in 2024, then decreased by 24.34% to $375.1 million in 2025, then dropped by 1.48% to $369.5 million in 2026.
- Business Quant data shows PACB's Current Assets at $369.5 million in Q1 2026, $375.1 million in Q4 2025, and $394.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.19 Bn | 194.59 Bn | 7.27 Bn | 24.52 Bn |
| 2 | Stryker | 129.95 Bn | 126.47 Bn | 4.50 Bn | 14.42 Bn |
| 3 | Medtronic | 120.06 Bn | 110.84 Bn | 6.41 Bn | 24.79 Bn |
| 4 | Boston Scientific | 74.14 Bn | 73.60 Bn | 3.85 Bn | 7.97 Bn |
| 5 | Edwards Lifesciences | 52.74 Bn | 48.49 Bn | 1.35 Bn | 6.82 Bn |
| 6 | Dexcom | 34.60 Bn | 32.65 Bn | 830.00 Mn | 4.09 Bn |
| 7 | GE HealthCare Technologies | 34.20 Bn | 32.10 Bn | 2.18 Bn | 10.50 Bn |
| 8 | Koninklijke Philips | 26.46 Bn | 23.13 Bn | 4.55 Bn | 10.84 Bn |
| 9 | Steris | 23.25 Bn | 22.77 Bn | 684.20 Mn | 2.45 Bn |
| 10 | Pacific Biosciences Of California | 396.09 Mn | 159.21 Mn | 12.64 Mn | 338.64 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 338.64 Mn |
| Mar 31, 2026 | 369.52 Mn |
| Dec 31, 2025 | 375.05 Mn |
| Sep 30, 2025 | 394.24 Mn |
| Jun 30, 2025 | 413.40 Mn |
| Mar 31, 2025 | 444.92 Mn |
| Dec 31, 2024 | 495.68 Mn |
| Sep 30, 2024 | 584.23 Mn |
| Jun 30, 2024 | 628.14 Mn |
| Mar 31, 2024 | 677.02 Mn |
| Dec 31, 2023 | 742.05 Mn |
| Sep 30, 2023 | 882.30 Mn |
| Jun 30, 2023 | 935.55 Mn |
| Mar 31, 2023 | 981.11 Mn |
| Dec 31, 2022 | 852.07 Mn |
| Sep 30, 2022 | 913.90 Mn |
| Jun 30, 2022 | 970.29 Mn |
| Mar 31, 2022 | 1.03 Bn |
| Dec 31, 2021 | 1.10 Bn |
| Jun 30, 2021 | 1.19 Bn |